Hopkinson Craig C. 4
4 · Alkermes plc. · Filed Feb 6, 2026
Research Summary
AI-generated summary of this filing
Alkermes (ALKS) EVP/CMO Craig Hopkinson Receives Award; Sells Shares for Taxes
What Happened
Craig Hopkinson, EVP R&D and Chief Medical Officer at Alkermes (ALKS), acquired 25,352 ordinary shares on Feb 5, 2026 due to the vesting of performance-vesting restricted stock units (2023 PRSUs). To satisfy related tax withholding, 7,454 of those shares were surrendered/disposed at $33.55 per share for a reported value of $250,082.
Key Details
- Transaction date: 2026-02-05 (Form 4 filed 2026-02-06). Filing was submitted the next day.
- Acquired: 25,352 shares (award/vesting; transaction code A).
- Disposed/withheld for taxes: 7,454 shares at $33.55 each, total $250,082 (transaction code F).
- Shares owned after transaction: not specified in the filing.
- Footnote: The 25,352 shares are from 2023 PRSUs with a three-year performance period ending 12/31/2025; this represents the final vesting event after pre-specified performance goals and a relative total shareholder return modifier.
Context
This was a vesting/tax-withholding event (not an open-market sale). The withholding of shares to cover taxes is a routine administrative step and does not, by itself, signal a discretionary sale or change in insider sentiment.
Insider Transaction Report
Form 4
Alkermes plc.ALKS
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Transactions
- Award
Ordinary Shares
[F1]2026-02-05+25,352→ 83,092 total - Tax Payment
Ordinary Shares
2026-02-05$33.55/sh−7,454$250,082→ 75,638 total
Footnotes (1)
- [F1]These ordinary shares were acquired by the reporting person as a result of the vesting of performance-vesting restricted stock unit awards granted to the reporting person on February 23, 2023 with a three-year performance period that ended on December 31, 2025 (the "2023 PRSUs"). The vesting of this portion of the 2023 PRSUs was triggered by the determination of achievement of certain pre-specified performance goals and application of a relative total shareholder return modifier and represents the final vesting event under the 2023 PRSUs.
Signature
/s/ Shantale Greenson, attorney-in-fact for Craig C. Hopkinson|2026-02-06